Roche to begin Actemra/RoActemra trial with COVID-19 pneumonia patients

This article was originally published here

The company is working with the US Food & Drug Administration (FDA) to commence a randomised, double-blind and placebo-controlled phase III clinical trial in collaboration with the Biomedical

The post Roche to begin Actemra/RoActemra trial with COVID-19 pneumonia patients appeared first on Pharmaceutical Business review.

0 replies

Leave a Reply

Want to join the discussion?
Feel free to contribute!

Leave a Reply